Analysis and characterization of hepatitis B vaccine particles synthesized from Hansenula polymorpha

Vaccine

Volumn 26, Issue 33, 2008, Pages 4138-4144

  Seo, Hyuk Seong ^a   Park, Jin Seung ^a   Han, Kyung Yeon ^a   Bae, Kyung Dong ^b   Ahn, Sang Jeom ^b   Kang, Hyun Ah ^c   Lee, Jeewon ^a  

^a Korea University   (South Korea)

^b Berna Biotech Korea Corp   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Covalent multimer; Glycosylation; Hepatitis B surface antigen; Stability; Yeast

Indexed keywords

DNA VACCINE; HEPATITIS B VACCINE; MEMBRANE PROTEIN; RECOMBINANT DNA; VIRUS ANTIGEN;

ARTICLE; DENATURATION; DRUG STABILITY; DRUG SYNTHESIS; ELECTROPHORESIS; GLYCOSYLATION; HANSENULA; HANSENULA POLYMORPHA; HEPATITIS B; IMMUNOBLOTTING; MOLECULAR INTERACTION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

BLOTTING, WESTERN; DIMERIZATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GLYCOSYLATION; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; MACROMOLECULAR SUBSTANCES; PICHIA; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 47149115664     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.05.070     Document Type: Article

References (34)

1. Padmapriyadarsini C., Chandrabose J., Victor L., Hanna L.E., Arunkumar N., and Swaminathan S. Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency virus and effect of anti-tuberculosis drugs on liver function. J Postgrad Med 52 2 (2006) 92-96
2. Kane M.A., and Clements J. In: Jamison D.T., Mosley W.H., Meashan A.R., and Bobadilla J. (Eds). Hepatitis B in Disease Control Priorities in Developing Countires (1993), World Bank Book, Oxford University Press, New York 321-330
3. Chang M.H., and Hepatitis. B virus infection. Semin Fetal Neonatal Med 12 3 (2007) 160-167
4. Park K. Textbook of prevention and social medicine. 15th edn. (1997), M/S Banarsidas Bhanot Publishers, Jabalpur, India 159
5. Hussain Z., Ali S.S., Husain S.S., Raish M., Sharma D.R., and Kar P. Evaluation of immunogenicity and reactogenicity of recombinant DNA hepatitis B vaccine produced in India. World J Gastroenterol 11 45 (2005) 7165-7168
6. Thyagarajan S.P., Jayaram S., and Mohanavalli B. Prevalence of HBV in general population in India. In: Sarin S.P., and Singhal A.K. (Eds). Hepatitis B in India: Problems and Prevention (1996), CBS Publications, New Delhi 5-16
7. Zuckerman J.N. Vaccination against hepatitis A and B: developments, deployment and delusions. Curr Opin Infect Dis 19 5 (2006) 456-459
8. Chen C.J., You S.L., Lin L.H., Hsu W.L., and Yang Y.W. Cancer epidemiology and control in Taiwan: a brief review. Jpn J Clin Oncol 32 Suppl. (2002) S66-S81
9. Arslanoglu I., Cetin B., Isguven P., and Karavus M. Anti-HBs response to standard hepatitis B vaccination in children and adolescents with diabetes mellitus. J Pediatr Endocrinol Metab 15 4 (2002) 389-395
10. Cook I.F., and Murtagh J. Comparative immunogenicity of hepatitis B vaccine administered into the ventrogluteal area and anterolateral thigh in infants. J Paediatr Child Health 38 4 (2002) 393-396
11. Abraham B., Baine Y., De-Clercq N., Tordeur E., Gerard P.P., Manouvriez P.L., and Parenti D.L. Magnitude and quality of antibody response to a combination hepatitis A and hepatitis B vaccine. Antiviral Res 53 1 (2002) 63-73
12. Cassidy W.M. Adolescent hepatitis B vaccination. A review. Minerva Pediatr 53 6 (2001) 559-566
13. lkayam O., Yaron M., and Caspi D. Safety and efficacy of vaccination against hepatitis B in patients with rheumatoid arthritis. Ann Rheum Dis 61 7 (2002) 623-625
14. Lee J., Park J.S., Moon J.Y., Kim K.Y., and Moon H.M. The influence of glycosylation on secretion, stability, and immunogenicity of recombinant HBV pre-S antigen synthesized in Saccharomyces cerevisiae. Biochem Biophys Res Commun 303 2 (2003) 427-432
15. Neurath A.R., and Kent S.B. The pre-S region of hepadnavirus envelope proteins. Adv Virus Res 34 (1988) 65-142
16. Gerlich W.H., Deepen R., Heermann K.H., Krone B., Lu X.Y., Seifer M., and Thomssen R. Protective potential of hepatitis B virus antigens other than S gene protein. Vaccine 8 Suppl. (1990) S63-S68
17. Famm K., Hansen L., Christ D., and Winter G. Thermodynamically Stable Aggregation-Resistant Antibody Domains through Directed Evolution. J Mol Biol 376 (2008) 926-931
18. Kim S.W., Kim Y.H., and Lee J. Thermal stability of human ferritin: concentration dependence and enhanced stability of an N-terminal fusion mutant. Biochem Biophys Res Commun 289 1 (2001) 125-129
19. Shibuya N., Goldstein I.J., Van Damme E.J., and Peumans W.J. Binding properties of a mannose-specific lectin from the snowdrop (Galanthus nivalis) bulb. J Biol Chem 263 2 (1988) 728-734
20. Shibuya N., Goldstein I.J., Broekaert W.F., Nsimba-Lubaki M., Peeters B., and Peumans W.J. The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac(alpha 2-6)Gal/GalNAc sequence. J Biol Chem 262 (1987) 1596-1601
21. Wang W.C., and Cummings R.D. The immobilized leukoagglutinin from the seeds of Maackia amurensis binds with high affinity to complex-type Asnlinked oligosaccharides containing terminal sialic acid-linked alpha-2,3 to penultimate galactose residues. J Biol Chem 263 (1988) 4576-4585
22. Crowley J.F., Goldstein I.J., Arnarp J., and Lönngren J. Carbohydrate binding studies on the lectin from Datura stramonium seeds. Arch Biochem Biophys 231 (1984) 524-533
23. Goldstein I.J., and Hayes C.E. The lectins: carbohydrate-binding proteins of plants and animals. Adv Carbohydr Chem Biochem 35 (1978) 127-340
24. Wampler D.E., Lehman E.D., Boger J., McAleer W.J., and Scolnick E.M. Multiple chemical forms of hepatitis B surface antigen produced in yeast. Proc Natl Acad Sci 82 (1985) 6830-6834
25. Diminsky D., Schirmbeck R., Reimann J., and Barenholz Y. Comparison between hepatitis B surface antigen (HBsAg) particles derived from mammalian cells (CHO) and yeast cells (Hansenula polymorpha): composition, structure and immunogenicity. Vaccine 15 (1997) 637-647
26. Santacruz-Toloza L., Huang Y., John S.A., and Papazian D.M. Glycosylation of shaker potassium channel protein in insect cell culture and in Xenopus oocytes. Biochemistry 33 (1994) 5607-5613
27. Waechter C.J., Schmidt J.W., and Catterall W.A. Glycosylation is required for maintenance of functional sodium channels in neuroblastoma cells. J Biol Chem 258 (1983) 5117-5123
28. Sonveaux N., Conrath K., Capiau C., Brasseur R., Goormaghtigh E., and Ruysschaert J.-M. The topology of the S protein in the yeast-derived hepatitis B surface antigen particles. J Biol Chem 269 (1994) 25637-25645
29. Eble B.E., Lingappa V.R., Ganem D., and Hepatitis. B surface antigen: an unusual secreted protein initially synthesized as a transmembrane polypeptide. Mol Cell Biol 6 5 (1986) 1454-1463
30. Eble B.E., MacRae D., Lingappa V., and Ganem D. Multiple topogenic sequences determine the transmembrane orientation of the hepatitis B surface antigen. Mol Cell Biol 7 10 (1987) 3591-3601
31. Kobayashi M., Asano T., Utsunomiya M., Itoh Y., Fujisawa Y., Nishimura O., Kato K., and Kakinuma A. Recombinant hepatitis B virus surface antigen carrying the pre-S2 region derived from yeast: purification and characterization. J Biotechnol 8 (1988) 1-22
32. Dreesman G.R., Hollinger F.B., Suriano J.R., Fujioka R.S., Brunschwig J.P., and Melnick J.L. Biophysical and biochemical heterogeneity of purified hepatitis B antigen. J Virol 10 (1972) 469-476
33. Famm K., Hansen L., Christ D., and Winter G. Thermodynamically Stable Aggregation-Resistant Antibody Domains through Directed Evolution. J Mol Biol 376 (2008) 926-931
34. Ahn J.Y., Choi H., Kim Y.H., Han K.Y., Park J.S., Han S.S., and Lee J. Heterologous gene expression using self-assembled supra-molecules with high affinity for HSP70 chaperone. Nucleic Acids Res 33 12 (2005) 3751-3762